Actinogen Medical Ltd (ACW) TRADING HALT SUSPENDED

20mins delayed

Movement

1 Year Return


Actinogen Medical Ltd Chart

Share price
Last
Change
Volume
Turnover
Market Cap $31.92 million
Today's Movement
Prev. Close
Open
Day Range -
VWAP
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover
(delayed)

ACW Statistics

27 November

1,454 / 2,246

ASX Size Rank

1yr Return

vs Sector (1yr)

-59.43%

vs ASX 200 (1yr)

-43.96%

$31.92 million

Market Cap

Share Issue

1.45 billion

All Ords (%)

N/A

Short Sold

0%

Current Fundamentals

27 November

N/A

PE Ratio

EPS ($)

-0.005

Earnings Yield

-21.82%

NTA ($)

0.01

0.00%

Dividend Yield

DPS ($)

-

Gross Div. Yield

-

Gross DPS ($)

-

Company Overview

Actinogen Medical Limited (ACW, formerly Actinogen Limited) is an ASX-listed biotechnology company developing innovative treatments for Alzheimer's disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases, like Type 2 diabetes. It focusses on the development of Xanamem, a novel treatment for Alzheimer's disease and the cognitive deficiency associated with other neurological and metabolic diseases within Australia.

Former Names
Actinogen Limited (ACW), 17/11/2015

Actinogen Medical Ltd Logo

Corporate Details

Head Office: Sydney
Managing Director: John (Bill) Ketelbey
GICS Sub-Industry: Biotechnology
Date Listed: 16 Oct 2007
Registry: Link Market Services
Similar Companies: CSL / MSB / CUV / OPT / AVH

Upcoming Calendar

18 Feb 2021 Report (Interim)
25 Aug 2021 Report (Prelim)
25 Aug 2021 Report (Annual)
25 Oct 2021 Report (Annual)

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.

Announcements

Date Heading Pages File Size Time

Announcements provided by

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

ACW is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.

Directors & Management

About the Data


Name Title Since Bio
Dr George Morstyn Non-Executive Director Dec 2017
Mr Malcolm John McComas Non-Executive Director Apr 2019
Dr Geoffrey E.D Brooke Non-Executive Chairman, Non-Executive Director Mar 2017
Dr John (Bill) William Ketelbey Chief Executive Officer, Managing Director Dec 2014

Director Transactions

About the Data

ACW directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
17/11/20 George Morstyn Issued 40,000 $0.022 $880 Rights issue.
17/11/20 Malcolm McComas Issued 100,000 $0.022 $2,200 Rights issue.
17/11/20 Geoffrey Brooke Issued 265,000 $0.022 $5,830 Rights issue.
17/11/20 John (Bill) Ketelbey Issued 128,579 $0.022 $2,828 Rights issue.
17/11/20 John (Bill) Ketelbey Issued 1,862,182 $0.022 $40,968 Rights issue.
31/01/20 John (Bill) Ketelbey Cancelled 3,000,000 $0.035 $105,000 Cancellation of securities.
22/11/19 John (Bill) Ketelbey Transfer 9,000,000 $0.050 $450,000 As advised by the company.
12/04/19 Malcolm McComas Issued 3,000,000 $0.052 $156,000 Issue of options.
13/12/18 George Morstyn Issued 1,500,000 $0.048 $72,000 Issue of options.
13/12/18 Geoffrey Brooke Issued 4,900,000 $0.048 $235,200 Issue of options.
13/12/18 John (Bill) Ketelbey Issued 11,700,000 $0.048 $561,600 Issue of options.
13/07/18 Geoffrey Brooke Issued 300,000 $0.050 $15,000 Participation in share purchase plan.
13/07/18 John (Bill) Ketelbey Issued 300,000 $0.050 $15,000 Participation in share purchase plan.
01/06/18 George Morstyn Buy +200,000 $0.051 $10,282 On-market trade.
22/01/18 Geoffrey Brooke Issued 625,000 $0.040 $25,000 Placement.
22/01/18 Geoffrey Brooke Issued 312,500 $0.041 $12,812 Placement.
21/12/17 Geoffrey Brooke Issued 53,333 $0.044 $2,346 Issue of options.
21/12/17 Jason Loveridge Issued 3,716,677 $0.044 $163,533 Issue of options.
21/12/17 John (Bill) Ketelbey Issued 1,647,172 $0.044 $72,475 Issue of options.
06/07/17 Anton Uvarov Transfer 187,244 $0.061 $11,473 Off-market transfer.
29/03/17 Geoffrey Brooke Buy +400,000 $0.066 $26,521 On-market trade.
24/03/17 Geoffrey Brooke Issued 5,000,000 $0.060 $300,000 Issue of securities.
24/12/15 John (Bill) Ketelbey Buy +10,909 $0.058 $629
20/05/15 John (Bill) Ketelbey Issued 157,894 $0.095 $15,000
20/05/15 Jason Loveridge Issued 157,894 $0.095 $15,000
20/05/15 Anton Uvarov Issued 157,894 $0.095 $15,000
20/05/15 Martin Rogers Issued 157,894 $0.095 $15,000
01/12/14 Anton Uvarov Buy +2,000,000 $0.020 $40,000
01/12/14 Brendan de Kauwe Buy +2,500,000 $0.020 $50,000
12/12/13 Daniel Parasiliti Issued 1,000,000 $0.010 $10,000
12/12/13 Brendan De Kauwe Issued 2,000,000 $0.010 $20,000
09/07/13 Zhukov (Zeke) Pervan Buy +66,666 $0.021 $1,381
02/07/13 Zhukov (Zeke) Pervan Transfer 9,333 $1.000 $9,333
02/07/13 Zhukov (Zeke) Pervan Transfer 933,334 $0.010 $9,333
19/06/13 Zhukov (Zeke) Pervan Transfer 5,666,666 $0.019 $107,666
19/06/13 David Zohar Buy +221,830 $0.019 $4,214
08/04/13 David Zohar Buy +142,017 $0.023 $3,266
02/04/13 David Zohar Buy +20,000 $0.022 $440
02/04/13 David Zohar Expiry 11,750,000 $0.021 $246,750

Shareholder Distribution

About the Data

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over Total Shareholders
No. of Shareholders 58 92 225 1,562 1,031 2,968

Top 20 Shareholders

About the Data

Name Shares Capital
HSBC Custody Nominees (Australia) Limited 227,303,623 20.36%
Edinburgh Technology Fund Limited 48,147,864 4.31%
Surfit Capital Pty Ltd 30,000,000 2.69%
Tisia Nominees Pty Ltd (Henderson Family A/C) 27,867,184 2.50%
Mrs Sarah Cameron 25,916,573 2.32%
Brazil Farming Pty Ltd 15,000,000 1.34%
Citicorp Nominees Pty Ltd 10,604,474 0.95%
Mr Steven Veronese 10,008,001 0.90%
Oaktone Nominees Pty Ltd (Grist Investment A/C) 10,000,000 0.90%
Mrs Gillian Karen Nes & Mrs Ronald Nes (Giro S/F A/C) 9,950,000 0.89%
Kaleidoscope Holdings Pty Ltd (Kaleidoscope Super A/C) 9,000,000 0.81%
Griffin & Grace Investments Pty Ltd (Griffin & Grace Inv S/F A/C) 8,800,000 0.79%
Mr Peter James Nixon 8,400,000 0.75%
Alua Capital Pty Ltd 8,000,000 0.72%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd Drp 7,738,901 0.69%
BNP Parabis Nominees Pty Ltd (Bnpp Nyb Clearing Acc Drp) 7,560,729 0.68%
Bannaby Investments Pty Ltd (Super Fund A/C) 7,500,000 0.67%
Webinvest Pty Ltd (Olsb Unit A/C) 7,000,000 0.63%
Romfal Sifat Pty Ltd (The Fizmail Family A/C) 7,000,000 0.63%
Paranji Super Fund Pty Ltd (Paranji Superfund A/C) 6,500,000 0.58%
All other shareholders 55.89 %


The Top 20 Shareholders of ACW hold 44.11% of shares on issue.

ACW Share Price History

Date Close Change % Change Open High Low Volume Turnover

ACW Historical Data

Download up to 20 years of share price history.


Year Closing Price (30 June) Last Trade
2020 $0.022 30 June
2019 $0.01 28 June
2018 $0.048 29 June
2017 $0.061 28 June
2016 $0.072 28 June
2015 $0.072 30 June
2014 $0.011 30 June

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Development of Xanamem, a novel treatment for Alzheimer's disease and the cognitive deficiency associated with other neurological and metabolic diseases.

Incorporated: Actinogen Limited was incorporated on 26/03/1999 in Western Australia.

Suite 901, Level 9, 109 Pitt St
Sydney NSW 2000


All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.